synbiology
Providing up to date news, answering questions and gathering opinions about Synthetic Biology.
CRISPR 101: Applications and Future Potential
CRISPR 101: Applications and Future Potential
By Kevin Holden, PhD, Head of Synthetic Biology at Synthego
This is the second part in the CRISPR 101 series...
146 Synthetic Biology Companies and Investors
No longer a confusing amalgam of disciplines, synthetic biology is at the forefront of biotech. In the last decade, the span and expectation of...
CRISPR 101: What is CRISPR-Cas9?
CRISPR 101: What is CRISPR-Cas9?
By Kevin Holden, PhD, Head of Synthetic Biology at Synthego
This is the first part in the CRISPR 101 series by...
Arzeda raises $12m to accelerate scale up
Seattle-based Arzeda, a synthetic biology company with roots at the University of Washington, announced it has raised $12 million in a Series A fundraising...
Storing data with DNA
With the amount of digital data growing exponentially worldwide, data storage is posing a huge headache for consumers, organisations and businesses worldwide looking to...
Synthetic Biology Market
The global Synthetic Biology Market is fuelled by extensive research in DNA sequencing and rising governmental support. The growing importance of synthetic biology can...
